Allele Frequency Net Database
  About us Links Publications Automated Access FAQs Contact
Home Populations HLA KIR Other polymorphisms HLA-ADR KDDB  

KIR » KIR allele/gene frequency search

Please specify your search by selecting options from boxes. Then, click "Search" to find KIR allele / gene frequencies that match your criteria. Remember at least one option must be selected.
Gene:  Starting Allele:  Ending Allele:     (Select your allele or leave both empty to include all alleles)
Select specific alleles    (If you want to pick specific alleles, make sure your alleles are within the Start-End range above)
Select your alleles   Clear All   Hide
Population:  Country:  Source of dataset: 
Region:  Ethnic Origin:     Type of study:  Sort by: 
Sample Size:      Sample Year:      Level of resolution :   (Click here for further details)
Show frequencies: All Only positives Only negatives
Displaying 1 to 12 (from 12) records   Pages: 1 of 1  

Line Allele Population % of individuals
that have the allele/gene
(3 decimals)
Distribution² Notes³
 1  2DL1  Uganda Kampala KIR 99.0  492See
 2  2DL2  Uganda Kampala KIR 61.0  492See
 3  2DL3  Uganda Kampala KIR 85.0  492See
 4  2DL5  Uganda Kampala KIR 65.0  492See
 5  2DP1  Uganda Kampala KIR 98.0  492See
 6  2DS1  Uganda Kampala KIR 24.0  492See
 7  2DS2  Uganda Kampala KIR 54.0  492See
 8  2DS3  Uganda Kampala KIR 24.0  492See
 9  2DS4  Uganda Kampala KIR 96.0  492See
 10  2DS5  Uganda Kampala KIR 50.0  492See
 11  3DL1  Uganda Kampala KIR 98.0  492See
 12  3DS1  Uganda Kampala KIR 12.0  492See


* Allele Frequency: Total number of copies of the allele in the population sample (Alleles / 2n) in three decimal format.
* % of individuals that have the allele: Percentage of individuals who have the allele or gene in the population (Individuals / n).

¹ IPD-KIR Database - For more details of the allele.
² Distribution - Graphical display of the distribution of the allele.
³ Notes - See notes for ambiguous combinations of alleles.


Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.
Gonzalez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, Silva AL, Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR and Middleton D Nucleic Acid Research 2015, 39, 28, D784-8.
Liverpool, U.K.

Valid XHTML 1.0 Transitional